ICD-coded information on sites of metastasis in oncology real-world data is specific but not sensitive Published May 2018 Citation Parrinello, C.M., Seidl-Rathkopf, K.N., Bennette, C, Bourla, A.B., Nussbaum, N.C., Carson, K.R., Abernethy, A.P. . ISPOR Annual Meeting. . https://4076230.fs1.hubspotusercontent-na1.net/hubfs/4076230/flatiron-com-pdf/Sites-of-Mets-Structured-vs-Unstructured-ISPOR-2018-Poster_Vertical_Final_MM.pdf Authors: Sources:ISPOR Annual Meeting Share Posted inPublications More publicationsASCO GUFebruary 2026Persistent gaps in BRCA mutation testing among mCRPC patients: Insights from US cancer practices (2018–2024)McKay R, Li W, Roose J, et al.Publication summaryPublicationsProstate cancerASCO GUFebruary 2026Treatment patterns and survival outcomes among lutetium 177-experienced patients with metastatic castration-resistant prostate cancertran B, Dorff T, Richey M, et al.Publication summaryPublicationsProstate cancerASCO GUFebruary 2026Opportunities for precision oncology: Real-world patterns and disparities in FGFR3 testing among US patients with locally advanced/metastatic urothelial cancerSmyth E, Richey M, Patel K, et al. Publication summaryPublicationsUrothelial cell carcinoma